Skip to main content

Table 2 Demographic and clinical characteristics of the participants

From: Assessing real-world gait with digital technology? Validation, insights and recommendations from the Mobilise-D consortium

Characteristic (unit of measure) or [range]

HA (n = 20)

CHF (n = 12)

COPD (n = 17)

MS (n = 20)

PD (n = 20)

PFF (n = 19)

Number of walking bouts included in the analyses (n)

1343

416

1031

795

681

684

Age (years)

71.7 ± 5.8

69.1 ± 11.7

69.4 ± 9.1

48.7 ± 9.7

69.8 ± 7.2

80.0 ± 8.5

Height (cm)

1.66 ± 0.10

1.74 ± 0.10

1.69 ± 0.07

1.71 ± 0.13

1.73 ± 0.07

1.69 ± 0.08

Weight (kg)

75.1 ± 11.8

84.5 ± 16.8

73.7 ± 14.2

84.0 ± 22.9

78.2 ± 14.4

68.4 ± 16.0

Gender: % females [females n, males n]

45% [9, 11]

33% [4, 8]

47% [8, 9]

45% [9, 11]

20% [4, 16]

58% [8, 11]

WS during the 2.5-h assessment (mean and [range]) (m/s)

0.59 [0.12, 1.63]

0.72 [0.14, 1.46]

0.60 [0.11, 1.36]

0.58 [0.15, 1.60]

0.60 [0.10, 1.44]

0.54 [0.14, 1.29]

Walking Aid use: % of users [n]

5% [1]

25% [3]

6% [1]

25% [5]

30% [6]

68% [13]

MoCA [0–30]

27.7 ± 2.6

27.1 ± 2.9

24.6 ± 3.4

26.7 ± 3.1

24.6 ± 4.0

24.1 ± 4.2

LLFDI [0–100]

73.53 ± 14.22

67.29 ± 21.35

59.07 ± 7.96

57.34 ± 10.66

60.26 ± 12.51

52.59 ± 16.61

Hoehn & Yahr stage (n)

    

H&Y I: 4

H&Y II: 11

H&Y III: 5

 

MDS-UPDRS III [0–132]

    

28.4 ± 13.6

 

EDSS [0–6]

   

3.5 ± 1.7

  

SPPB [0–12]

     

6.2 ± 3.9

CAT Score [0–40]

  

16.6 ± 8.9

   

FEV1 (litres)

  

1.6 ± 0.6

   

6MWT distance (m)

 

370.7 ± 115.6

357.6 ± 88.5

   

KCCQ-12 Score [0–100]

 

80.5 ± 20.2

    
  1. Values are presented as mean ± standard deviation, unless otherwise stated
  2. CAT chronic obstructive pulmonary disease (COPD) Assessment Test; EDSS Expanded Disability Status Scale; FEV1 Forced Expiratory Volume in 1 Second; KCCQ-12 Kansas City Cardiomyopathy Questionnaire-12; LLFDI Late Life Function and Disability Instrument; MDS-UPDRS III Movement Disorder Society Unified Parkinson’s Disease Rating Scale Part III; MoCA Montreal Cognitive Assessment; SPPB Short Physical Performance Battery; 6MWT 6 Minute Walking Test; HA healthy adults; PD Parkinson’s disease; MS multiple sclerosis; COPD chronic obstructive pulmonary disease; CHF congestive heart failure; PFF proximal femoral fracture